ARTICLE | Distillery Therapeutics
Therapeutics: Mannosyl (β-1,4-)-glycoprotein β-1,4-N-acetylglucosaminyltransferase (MGAT3)
October 15, 2015 7:00 AM UTC
In vitro and mouse studies identified an MGAT3 inhibitor that could help treat Type II diabetes by interfering in its role in the biosynthesis of triacylglycerol (TAG). Chemical synthesis and testing ...